Many theories of cognitive aging are based on evidence that dopamine (DA) declines with age. Here, we performed a systematic meta-analysis of cross-sectional positron emission tomography and single-photon emission-computed tomography studies on the average effects of age on distinct DA targets (receptors, transporters, or relevant enzymes) in healthy adults (N = 95 studies including 2611 participants). Results revealed significant moderate to large, negative effects of age on DA transporters and receptors. Age had a significantly larger effect on D1- than D2-like receptors. In contrast, there was no significant effect of age on DA synthesis capacity. The average age reductions across the DA system were 3.7%-14.0% per decade. A meta-regressi...
Dopamine transporter imaging is a valuable tool to investigate the integrity of the dopaminergic neu...
Past research has shown that as individuals age, there are decreases in within-network connectivity ...
The dopamine D(1), D(2), D(3) receptors, vesicular monoamine transporter type-2 (VMAT2), and dopamin...
Aging is accompanied by profound changes in the brain's dopamine system that affect cognitive functi...
Past research has demonstrated that performance on frontal lobe-dependent tasks is associatedwith do...
Age-related dopamine (DA) losses have been extensively demon-strated for the D2 receptor subtype. Co...
Summary: Age-related alterations in D1-like dopamine receptor (D1DR) have distinct implications for ...
Age-related dopamine (DA) losses have been extensively demon-strated for the D2 receptor subtype. Co...
Dopaminergic signaling in striatum is strongly implicated in executive functions including cognitive...
BACKGROUND AND OBJECTIVES: Cross-sectional studies suggest marked dopamine (DA) decline in aging, bu...
Purpose Age-related decline in cognitive speed has been associated with prefrontal dopamine D1 recep...
Aging compromises dopamine transporter (DAT) and receptor mechanisms in the frontostriatal circuitry...
Despite dopamine's significant role in models of value-based decision-making and findings demonstrat...
The brain neuronal systems defined by the neurotransmitter dopamine (DA) have since long a recognize...
Dopamine (DA) integrity is suggested as a potential cause of individual differences in working memor...
Dopamine transporter imaging is a valuable tool to investigate the integrity of the dopaminergic neu...
Past research has shown that as individuals age, there are decreases in within-network connectivity ...
The dopamine D(1), D(2), D(3) receptors, vesicular monoamine transporter type-2 (VMAT2), and dopamin...
Aging is accompanied by profound changes in the brain's dopamine system that affect cognitive functi...
Past research has demonstrated that performance on frontal lobe-dependent tasks is associatedwith do...
Age-related dopamine (DA) losses have been extensively demon-strated for the D2 receptor subtype. Co...
Summary: Age-related alterations in D1-like dopamine receptor (D1DR) have distinct implications for ...
Age-related dopamine (DA) losses have been extensively demon-strated for the D2 receptor subtype. Co...
Dopaminergic signaling in striatum is strongly implicated in executive functions including cognitive...
BACKGROUND AND OBJECTIVES: Cross-sectional studies suggest marked dopamine (DA) decline in aging, bu...
Purpose Age-related decline in cognitive speed has been associated with prefrontal dopamine D1 recep...
Aging compromises dopamine transporter (DAT) and receptor mechanisms in the frontostriatal circuitry...
Despite dopamine's significant role in models of value-based decision-making and findings demonstrat...
The brain neuronal systems defined by the neurotransmitter dopamine (DA) have since long a recognize...
Dopamine (DA) integrity is suggested as a potential cause of individual differences in working memor...
Dopamine transporter imaging is a valuable tool to investigate the integrity of the dopaminergic neu...
Past research has shown that as individuals age, there are decreases in within-network connectivity ...
The dopamine D(1), D(2), D(3) receptors, vesicular monoamine transporter type-2 (VMAT2), and dopamin...